Treatment of acanthamoeba keratitis by corneal cross-linking

Cornea

Volumn 32, Issue 2, 2013, Pages 174-178

  Berra, Martín ^a   Galperín, Gustavo ^a,b   Boscaro, Gabriela ^c   Zarate, Jorge ^a   Tau, Julia ^a   Chiaradia, Pablo ^a   Berra, Alejandro ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Hospital Pedro Lagleyze   (Argentina)

^c BioFundus   (Argentina)

Author keywords

Acanthamoeba; corneal infection; cross linking

Indexed keywords

PHOTOSENSITIZING AGENT; RIBOFLAVIN;

ACANTHAMOEBA KERATITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORNEA EDEMA; CORNEAL CROSS LINKING; CROSS LINKING; ENUCLEATION; HYPOPYON; INOCULATION; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SLIT LAMP; STROMA; ULTRAVIOLET A RADIATION;

ACANTHAMOEBA KERATITIS; ANIMALS; COLLAGEN; CORNEAL STROMA; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; PHOTOSENSITIZING AGENTS; RABBITS; RIBOFLAVIN; TREATMENT OUTCOME; ULTRAVIOLET RAYS;

EID: 84872959301     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31825cea99     Document Type: Article

References (25)

1. Illingworth CD, Cook SD. Acanthamoeba keratitis. Surv Ophthalmol. 1998;42:493-508. (Pubitemid 28272739)
2. Alizadeh H, Apte S, El-Agha MS, et al. Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea. 2001;20:622-627. (Pubitemid 32706199)
3. Naginton J, Watson PG, Playfair TJ, et al. Amoebic infection of the eye. Lancet. 1974;2:1537-1540.
4. Niederkorn JY, Alizadeh H, Leher H, et al. The pathogenesis of Acanthamoeba keratitis. Microbes Infect. 1999;1:437-443.
5. Auran JD, Starr MB, Jakobiec FA. Acanthamoeba keratitis. A review of the literature. Cornea. 1987;6:2-26.
6. Latapie LB, Cremona G, Carrasco MA, et al. Queratitis inflamatoria por Acanthamoeba spp: Análisis estructural por microscopía electrónica de transmisión. Parasitol Latinoam. 2003;58:159-165.
7. Sharma S, Srinivasan M, George C. Acanthamoeba keratitis in noncontact lens wearers. Arch Ophthalmol. 1990;108:676-678. (Pubitemid 20168824)
8. Martínez AJ, Visvesvara GS. Free-living, amphizoic and opportunistic amebas. Brain Pathol. 1997;7:583-598. (Pubitemid 27077054)
9. Khan NA. Acanthamoeba: Biology and increasing importance in human health. FEMS Microbiol Rev. 2006;30:564-595. (Pubitemid 43855767)
10. Rau H. A transportable apparatus for UV irradiation in final disinfection of patient rooms [in German]. Dtsch Gesundheitsw. 1960;15:148-151.
11. Makdoumi K, Mortensen J, Sorkhabi O, et al. UVA-riboflavin photochemical therapy of bacterial keratitis: A pilot study. Graefes Arch Clin Exp Ophthalmol. 2012;250:95-102.
12. Galperin G, Berra M, Tau J, et al. Treatment of fungal keratitis from Fusarium infection by corneal cross-linking. Cornea. 2012;31: 176-180.
13. Aksozek A, McClellan K, Howard K, et al. Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol. 2002;88:621-623. (Pubitemid 34686531)
14. Hijnen WA, Beerendonk EF, Medema GJ. Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water: A review. Water Res. 2006;40:3-22. (Pubitemid 43021298)
15. Ozturk F, Yavas GF, Kusbeci T, et al. Efficacy of topical caspofungin in experimental Fusarium keratitis. Cornea. 2007;26:726-728. (Pubitemid 47080294)
16. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627. (Pubitemid 36457967)
17. Muller G, GoetheH, Herrmann R. Ship drinking water disinfection using UV irradiation. II [in German]. Zentralbl Bakteriol Orig B. 1972;156:361-372.
18. Tsugita A, Okada Y, Uehara K. Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochim Biophys Acta. 1965; 103:360-363.
19. Asano H, Lee CY, Fox-Talbot K, et al. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation. 2007;84:1174-1182. (Pubitemid 350125361)
20. Goodrich RP. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang. 2000;78(suppl 2):211-215.
21. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35-40. (Pubitemid 39389439)
22. Kashiwabuchi RT, Carvalho FR, Khan YA, et al. Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest Ophthalmol Vis Sci. 2011;52:9333-9338.
23. del Buey MA, Cristóbal JA, Casas P, et al. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol. 2012;153:399-404.
24. Moren H, Malmsjo M, Mortensen J, et al. Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea. 2010;29:102-104.
25. Garduño-Vieyra L, Gonzalez-Sanchez CR, Hernandez-Da Mota SE. Ultraviolet-a light and riboflavin therapy for Acanthamoeba keratitis: A case report. Case Report Ophthalmol. 2011;2:291-295.